{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&tablingMemberConstituency=Lancaster+and+Fleetwood", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&tablingMemberConstituency=Lancaster+and+Fleetwood", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&tablingMemberConstituency=Lancaster+and+Fleetwood&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=0&tablingMemberConstituency=Lancaster+and+Fleetwood", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&tablingMemberConstituency=Lancaster+and+Fleetwood", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&tablingMemberConstituency=Lancaster+and+Fleetwood", "items" : [{"_about" : "http://data.parliament.uk/resources/1715999", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1715999/answer", "answerText" : {"_value" : "
The Department is proud to invest £1.3 billion per year in health research through the National Institute for Health and Care Research (NIHR). NIHR research expenditure for all cancers was over £121.8 million for 2022/23, and more is spent on cancer than any other disease group.<\/p>
<\/p>
The Government, through the NIHR, is committed to improving research into the cancers with the poorest survival rates, such as acute myeloid leukaemia, by funding high quality, timely research that leads to improved outcomes for patients and the public, and makes the health and social care system more efficient, effective, and safe. Research evidence is vital for improving treatments and outcomes for people, including those with pancreatic cancer, and other less survivable cancers. The following table shows NIHR research spend on diagnosis, treatment, and diagnosis and treatment of blood cancers, which includes leukaemia, since 2018:
<\/p>